DiabetesHeadlines.com



 

Diabetes News Archive


The Temecula Valley News - February 6, 2009, 23:57 GMT
Healthy Management Diabetes Education (HMDE), a local nonprofit, is offering free online diabetes education at www.hmde.org. Web site visitors will be able to instructional videos, become part of HMDE's e-mail string (monthly updates), find free diabetes classes and support groups, learn about HMDE's upcoming diabetes symposium and find additional diabetes resources. The site is funded by the ...

Mississauga News - February 6, 2009, 20:39 GMT
Peel Public Health announced today it will receive up to $1.15 million in special funding from the Ontario Ministry of Health Promotion to deliver two significant diabetes prevention programs in Peel over the next 15 months.

Lancet - February 6, 2009, 16:47 GMT
In collaboration with the American Diabetes Association's (ADA) 69th annual Scientific Sessions meeting, The Lancet will be publishing a special theme issue dedicated to diabetes research.

Jacksonville Daily Record - February 6, 2009, 15:23 GMT
by Joe Wilhelm Jr. The search for a cure for diabetes got an over $1 million boost from the North Florida Chapter of the Juvenile Diabetes Research Foundation (JDRF) last year and the organization is getting ready for this year's fundraising events.

Medical News Today - February 6, 2009, 14:14 GMT
Kaiser Permanente's Mid-Atlantic States Region announced their decision to enhance their existing diabetes education curriculum with Healthy Interactions U.S. Diabetes Conversation Map(R) tools, proclaiming them to be more effective in helping patients with diabetes live with their condition than traditional didactic education.

Medical News Today - February 6, 2009, 12:15 GMT
Professor Sir George Alberti has been appointed as the new Chairman of leading health charity Diabetes UK. Succeeding Professor Simon Howell, Professor Alberti is internally renowned in the field of diabetes and in the wider medical community.

Medical News Today - February 6, 2009, 12:13 GMT
Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH, NASDAQ: TTHI) announced the completion of patient enrolment for a Phase 2 clinical study of gastrin analogue, TT-223, in patients with type 2 diabetes.